Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Abrahamyan L, Feldman BM, Tomlinson G, et al. 2016 Alternative designs for clinical trials in rare diseases. Am. J. Med. Genet. C Semin. Med. Genet. 172 313–331
2. Al-Chalabi A and Hardiman O 2013 The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 9 617–628
3. Asher DR, Thapa K, Dharia SD, et al. 2020 Clinical development on the frontier: gene therapy for duchenne muscular dystrophy. Expert Opin. Biol. Ther. 20 263–274
4. CDSCO 2019 New drugs and clinical trials rule. The Gazette of India (https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDrugs_CTRules_2019.pdf)
5. Chakraborty M, Choudhury MC, Chakraborty I, et al. 2022 Rare disease patients in India are rarely involved in international orphan drug trials. PLoS Glob. Public Health 2 e0000890
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献